Related Experiment Video
Updated: Jul 24, 2026

Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care
P S Jensen1, S P Hinshaw, J M Swanson
1Center for the Advancement of Children's Mental Health, Department of Child Psychiatry, NYSPI/Columbia University, New York, New York 10032, USA. pj131@columbia.edu
Insights
The Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA) study found that combination treatment and medication management were superior for ADHD symptoms. Behavioral treatment alone was less effective, highlighting the benefits of combined or medication-focused approaches.
Area of Science:
- Child and Adolescent Psychiatry
- Behavioral Science
- Clinical Psychology
Background:
- Attention-Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder.
- Effective treatment strategies for ADHD are crucial for improving child outcomes.
- The Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA) study aimed to compare different treatment modalities.
Purpose of the Study:
- To evaluate the comparative effectiveness of different ADHD treatments.
- To assess the impact of medication management, behavioral treatment, and their combination.
- To examine treatment effects across various functional domains and specific child populations.
Main Methods:
- A multisite randomized clinical trial involving 579 children diagnosed with ADHD.
- Children were assigned to either community care (CC) or one of three study-delivered treatments: medication management (MedMgt), behavioral treatment (Beh), or a combination (Comb).
- Treatments lasted 14 months, with assessments at multiple time points across various outcome measures.
Main Results:
- Combination (Comb) and medication management (MedMgt) interventions were significantly more effective for ADHD symptoms than behavioral treatment (Beh) or community care (CC).
- The combination treatment showed slight advantages over single treatments and CC in social skills, academics, parent-child relations, and emotional well-being.
- High-quality medication management, including specific dosing and frequent follow-ups, yielded substantial benefits. Children with comorbid anxiety disorders particularly benefited from behavioral and combination treatments.
Conclusions:
- Combined behavioral and medication treatments, along with high-quality medication management, are highly effective for managing ADHD symptoms.
- Behavioral treatment alone is less effective than medication-focused or combined approaches for core ADHD symptoms.
- Tailoring interventions for children with comorbid conditions, such as anxiety, may enhance treatment outcomes.
Abstract:
In 1992, the National Institute of Mental Health and 6 teams of investigators began a multisite clinical trial, the Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA) study. Five hundred seventy-nine children were randomly assigned to either routine community care (CC) or one of three study-delivered treatments, all lasting 14 months. The three MTA treatments-monthly medication management (usually methylphenidate) following weekly titration (MedMgt), intensive behavioral treatment (Beh), and the combination (Comb)-were designed to reflect known best practices within each treatment approach. Children were assessed at four time points in multiple outcome. Results indicated that Comb and MedMgt interventions were substantially superior to Beh and CC interventions for attention-deficit hyperactivity disorder symptoms. For other functioning domains (social skills, academics, parent-child relations, oppositional behavior, anxiety/depression), results suggested slight advantages of Comb over single treatments (MedMgt, Beh) and community care. High quality medication treatment characterized by careful yet adequate dosing, three times daily methylphenidate administration, monthly follow-up visits, and communication with schools conveyed substantial benefits to those children that received it. In contrast to the overall study findings that showed the largest benefits for high quality medication management (regardless of whether given in the MedMgt or Comb group), secondary analyses revealed that Comb had a significant incremental effect over MedMgt (with a small effect size for this comparison) when categorical indicators of excellent response and when composite outcome measures were used. In addition, children with parent-defined comorbid anxiety disorders, particularly those with overlapping disruptive disorder comorbidities, showed preferential benefits to the Beh and Comb interventions. Parental attitudes and disciplinary practices appeared to mediate improved response to the Beh and Comb interventions.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.